MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from borrowings
on convertible...
$402,500K
Proceeds from equity
offerings
$257,128K
Proceeds from reissuance
of treasury stock
$87,872K
Proceeds from issuance of
common stock upon...
$19,223K
(516.32%↑ Y/Y)
Proceeds from issuance of
common stock under...
$13,585K
(15.92%↑ Y/Y)
Proceeds from unwinding
of convertible...
$5,030K
Other
$3,596K
(2450.33%↑ Y/Y)
Net cash provided by
(used in) financing...
$671,133K
(67482.83%↑ Y/Y)
Net effect of
foreign exchange rate...
$491K
(127.74%↑ Y/Y)
Canceled cashflow
$117,801K
Net (decrease)
increase in cash, cash...
-$140,338K
(72.15%↑ Y/Y)
Canceled cashflow
$671,624K
Maturities of marketable
debt securities
$307,323K
(778.07%↑ Y/Y)
Stock-based compensation
$166,217K
(18.38%↑ Y/Y)
Accounts payable and
accrued liabilities
$52,749K
(1970.53%↑ Y/Y)
Depreciation and
amortization
$39,736K
(-6.25%↓ Y/Y)
Operating lease costs
$33,577K
(7.85%↑ Y/Y)
Deferred revenue
$19,455K
(4.24%↑ Y/Y)
Impairment of
non-marketable equity...
$18,582K
Interest income received
on marketable debt...
$7,677K
Other assets, net
-$212K
(-108.93%↓ Y/Y)
Repurchase of treasury
stock
$45,010K
Employee taxes paid
related to net share...
$30,535K
(94.73%↑ Y/Y)
Payment of debt issuance
costs
$24,588K
Payment of equity
offering costs
$17,668K
Net cash (used in)
provided by investing...
-$627,202K
(-140.02%↓ Y/Y)
Canceled cashflow
$307,323K
Net cash used in
operating activities
-$184,760K
(22.97%↑ Y/Y)
Canceled cashflow
$338,205K
Revenue
$982,021K
(32.88%↑ Y/Y)
Purchases of marketable
debt securities
$818,231K
(166.24%↑ Y/Y)
Acquisition of business, net
of cash acquired
$58,988K
Purchases of property and
equipment
$48,306K
(37.68%↑ Y/Y)
Purchases of
non-marketable equity...
$9,000K
(20.00%↑ Y/Y)
Net loss
-$416,277K
(4.61%↑ Y/Y)
Canceled cashflow
$982,021K
Operating lease
liabilities
-$37,524K
(-3.90%↓ Y/Y)
Accounts receivable, net
$28,175K
(31.73%↑ Y/Y)
Inventory, net
$14,792K
(61.93%↑ Y/Y)
Gain on
extinguishment of convertible...
$13,672K
Prepaid expenses and
other current assets,...
$6,354K
(-17.38%↓ Y/Y)
Amortization of discount on
marketable debt securities
$5,877K
(-13.24%↓ Y/Y)
Other
$294K
(113.20%↑ Y/Y)
Sales and marketing
expense
$448,419K
(36.69%↑ Y/Y)
Cost of revenue
$337,195K
(32.47%↑ Y/Y)
Research and development
expense
$309,178K
(4.50%↑ Y/Y)
Other segment items
$157,361K
(13.48%↑ Y/Y)
General and
administrative expense
$146,145K
(9.59%↑ Y/Y)
Back
Back
Cash Flow
source: myfinsight.com
GuardantHealthMasterLogo_ND_RGBcropped-svg
Guardant Health, Inc. (GH)
GuardantHealthMasterLogo_ND_RGBcropped-svg
Guardant Health, Inc. (GH)